Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.
Clinical characteristics of Kawasaki disease and concurrent pathogens during isolation in COVID-19 pandemic.
复制标题
COVID-19大流行期间隔离期间川崎病和并发病原体的临床特征
DOI:
10.1007/s12519-021-00431-2
复制
发表时间:
2021-06
期刊:
影响因子:
--
通讯作者:
Lv HT
中科院分区:
文献类型:
--
作者:
Ding YY;Ren Y;Qin J;Qian GH;Tang YJ;Chen Y;Li X;Xu L;Qiao CH;Sun L;Lv HT
The aim of this study is to explore the characteristics of Kawasaki disease (KD) and concurrent pathogens due to a stay-at-home isolation policy during coronavirus disease 2019 (COVID-19) epidemic. All patients with KD admitted between February and April in 2015–2020, were classified into before (group 1, in 2015–2019) and after (group 2, in 2020) isolation groups. A total of 4742 patients [with KD (n = 98) and non-KD (n = 4644)] referred to Mycoplasma pneumoniae (MP) and virus detection were analyzed in 2020. Clinical characteristics, laboratory data, and 13 pathogens were analyzed retrospectively. Group 2 had a significantly increased incidence of KD (0.11%) with 107 patients compared to that of group 1 (0.03%) with 493 patients. The comparisons of oral mucosal change, strawberry tongue, desquamation of the fingertips, cervical lymphadenopathy and neutrophil percentage decreased in group 2 compared to group 1. The infection rate of MP increased significantly in group 2 (34.7%) compared to group 1 (19.3%), while the positive rate of viruses decreased significantly in group 2 (5.3%) compared to group 1 (14.3%). In 2020, the positive rate of MP infection increased significantly in patients with KD compared to the increase in patients with non-KD. The infection rate of MP for younger children aged less than 3 years old was higher in group 2 than in group 1. Compared with the characteristics of KD from 2015 to 2019 years, the incidence of KD was increased in 2020 and was accompanied by a high incidence of MP infection, especially in younger children (less than 3 years old) during the isolation due to COVID-19 pandemic.
登录
查看更多内容
影响因子:
1.6
作者:
Lan, Yinle;Li, Shuxian;Chen, Zhimin
通讯作者:
Chen, Zhimin
影响因子:
6.4
作者:
Rowley, AH;Baker, SC;Crawford, SE
通讯作者:
Crawford, SE
影响因子:
3
作者:
Huang, Shih-Hui;Chen, Chun-Yu;Wei, James Cheng-Chung
通讯作者:
Wei, James Cheng-Chung
影响因子:
3.5
作者:
Franco A;Shimizu C;Tremoulet AH;Burns JC
通讯作者:
Burns JC
影响因子:
1.4
作者:
Ayusawa, M;Sonobe, T;Harada, K
通讯作者:
Harada, K